Meletios A. Dimopoulos, MD, is Professor and Chairman of the Department of Clinical Therapeutics at the University Athens School of Medicine, Athens, Greece and was Vice Dean of the Medical School before taking up the position of Dean between 2011 and 2013.
Dr. Dimopoulos is internationally recognized for his contributions to multiple myeloma research and most recently for the role he has played as principal investigator for a number of pivotal clinical trials, that have led to new therapies reaching the clinic. He has authored and co-authored a large number of manuscripts in many areas of oncology. In 2017 he was awarded the Waldenström’s Award in recognition of his outstanding research and contributions in the field of multiple myeloma.
Dr. Dimopoulos studied Medicine at the University of Athens and completed his residency in internal medicine at the Royal Victoria Hospital, McGill University, Montreal, Canada. He then took up a fellowship in Hematology/Oncology at the University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA, where he worked for several years rising through the ranks of Junior Faculty Associate, Assistant Internist and Assistant Professor in both the Department of Hematology and Department of Clinical Therapeutics, Adjunct Assistant Professor of Medicine and Adjunct Assistant Professor of Medicine before he became Professor of Medicine in 2002. He has subsequently held several prestigious roles at the university.
Dr. Dimopoulos serves on the Scientific Advisory Boards of the Multiple Myeloma Research Foundation (MMRF) and the International Myeloma Foundation (IMF). He also works with the International Waldenstrom’s Macroglobulinemia Foundation and is a Board member for the European Myeloma Network. He joined the steering committee for the Multiple Myeloma Hub in April 2017.